Board Meetings for SANOFICONR
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 28 Apr 2026 | Financial Results | To consider and approve the Unaudited Financial Results of the Company for the quarter ended March 31, 2026 | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 28 Apr 2026 | Board Meeting Intimation | Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 28-Apr-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended March 2026 . | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 25 Feb 2026 | Dividend | To consider recommendation of dividend, if any, for the Financial Year ended 31st December 2025 at Board Meeting to be held on Wednesday, 25th February 2026. | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 25 Feb 2026 | Board Meeting Intimation | Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 25-Feb-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended December 2025 . | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 25 Feb 2026 | Financial Results | To consider and approve the Audited Financial Statements for the Quarter and Financial Year ended December 31, 2025 | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 12 Nov 2025 | Board Meeting Intimation | Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 . | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 12 Nov 2025 | Financial Results | To consider and approve the Unaudited Financial Results for the quarter and nine months ended 30th September 2025 | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 04 Aug 2025 | Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 04-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended June 2025 . | Board Meeting Intimation | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 04 Aug 2025 | Financial Results | To consider and approve the Unaudited Financial Results for the quarter and half-year ended 30th June 2025 | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 02 May 2025 | Board Meeting Intimation | Sanofi Consumer Healthcare India Limited has informed the Exchange about Board Meeting to be held on 02-May-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended March 2025 . | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 02 May 2025 | Financial Results | To consider and approve the Unaudited Financial Results for the Quarter ended 31st March 2025 | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 20 Feb 2025 | Board Meeting Intimation | Sanofi Consumer healthcare India Limited has informed the Exchange about Board Meeting to be held on 20-Feb-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended December 2024 and Dividend. | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 20 Feb 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2024 and dividend | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 12 Nov 2024 | Financial Results | To consider and approve the Unaudited Financial Statements (Standalone & Consolidated) for the Quarter and Nine months ended 30th September 2024. | |
| SANOFICONR | Sanofi Consumer Healthcare India Limited | 12 Nov 2024 | Board Meeting Intimation | SANOFI CONSUMER HEALTHCARE INDIA LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2024 . |
Showing page 1 of 1 (15 total items)